16 Oct 2026Fri,

Rapid Healthcares
Cancer

Aberdeen Study Aims to Uncover Male Breast Cancer Causes

A new study from the University of Aberdeen seeks to explore the unique biology of male breast cancer.

Investigation into Male Breast Cancer

Researchers at the University of Aberdeen are embarking on a significant study focusing on male breast cancer, aiming to understand its development and the biological contrasts with female breast cancer. Currently, in the UK, around 400 men are diagnosed with this disease each year, with Scotland accounting for approximately 40 of those cases.

Need for Male-Focused Research

This area of cancer research has historically been overlooked, resulting in delayed diagnoses and a lack of effective treatment options for men. Most clinical trials related to breast cancer predominantly emphasize female patients, leading to inadequate awareness surrounding the disease's impact on men.

The necessity for increased visibility on this topic has recently gained traction, particularly through a storyline on the popular soap opera, Coronation Street, which has sparked discussions regarding the symptoms and stigma surrounding male breast cancer.

Research Goals and Funding

Supported by a generous £300,000 grant from the Scottish Government’s Chief Scientist Office (CSO), Professor Valerie Speirs will spearhead a two-year investigation into cancer-associated fibroblasts (CAFs). These cells play a critical role in supporting tumors and can affect cancer growth, spread, and treatment responsiveness.

Through the study, the team aims to assess how these fibroblasts react to hormones such as estrogen and androgens, comparing the responses between male and female tumors and exploring factors that might influence CAF activity in men.

Significance of This Research

Professor Speirs emphasized the urgency for this research, noting, “Male breast cancer has been understudied for decades. By mapping the cells and signals that shape the disease in men, we hope to open the door to more personalized treatments.”

The timing of this study coincides with Breast Cancer Awareness Month, bringing attention to male breast cancer when visibility is needed the most. Following the recent media attention, organizations, including Breast Cancer Now, have reported an uptick in queries related to symptoms and risk factors among viewers.

Simon Vincent, the chief scientific officer at Breast Cancer Now, remarked on the importance of this research. “Although male breast cancer is rare, approximately 400 men are diagnosed annually in the UK. Research like this is crucial for enhancing our understanding and developing more personalized treatment options.”

Collaborative Efforts

This Aberdeen-based project will feature collaborations with prominent international groups, including GEICAM, Spain's leading breast cancer research organization, and the Male Breast Cancer Global Alliance, as well as engagement with affected individuals through The Virtual Men's Meetup.

Personal Journey: Dave Talbot's Experience

One such advocate for male breast cancer awareness is Dave Talbot, who discovered a lump in his chest while on vacation in 2015. His experience transformed him into a passionate supporter of further research into this underrepresented area of cancer.

After noticing the lump, he promptly sought medical attention, recalling how his GP initially reassured him it was likely benign but still referred him for additional tests. Following a definitive diagnosis of breast cancer, Dave experienced a whirlwind of emotions, from fear to anger, particularly given his family history with cancer.

Enduring a rigorous treatment regimen that included a mastectomy and chemotherapy, Dave emerged cancer-free in 2016. Despite this success, he remains vigilant with annual check-ups to monitor his health.

Advocacy and Awareness

Determined to raise awareness, he participated in various charitable events, including the MoonWalk London, and took part in national campaigns. His personal journey has led him to engage with audiences, aiming to spotlight the fact that men can develop breast cancer.

Through sharing his story, Dave highlights the critical need for tailored treatments specific to men. He emphasizes, “Research into male breast cancer is essential—treatment isn’t ‘one size fits all.’”

Living in Bristol with his family, including three grown children and six grandchildren, Dave continues to advocate for men’s health, reminding others of the importance of early intervention and awareness in battling this disease.

More from the newsroom

All stories